Table 1.
Characteristic | No. of Individuals | Person-Years | No. of Deaths |
---|---|---|---|
Estrogen-receptor status | |||
Negative | 242 | 2,727.6 | 60 |
Positive | 1,003 | 12,532.8 | 159 |
Missing | 495 | 6,405.5 | 50 |
Grade | |||
Well differentiated | 186 | 2,494.1 | 8 |
Moderately differentiated | 509 | 6,441.4 | 74 |
Poorly differentiated | 497 | 5,940.2 | 114 |
Missing | 548 | 6,790.1 | 73 |
Body mass indexa | |||
First quartile (14.53–22.89) | 435 | 5,489.7 | 61 |
Second quartile (22.94–25.28) | 434 | 5,500.2 | 60 |
Third quartile (25.31–28.08) | 431 | 5,396.8 | 64 |
Fourth quartile (28.13–52.34) | 440 | 5,279.1 | 84 |
Size of tumor, mm | |||
1–9 | 366 | 4,741.1 | 21 |
10–19 | 817 | 10,617.7 | 92 |
20–29 | 359 | 4,229.3 | 90 |
30–39 | 116 | 1,273.7 | 29 |
40–49 | 43 | 448.0 | 17 |
≥50 | 39 | 356.1 | 20 |
No. of affected lymph nodes | |||
0 | 1,253 | 16,323.2 | 110 |
1–3 | 335 | 3,954.7 | 78 |
4–9 | 106 | 1,069.9 | 47 |
≥10 | 46 | 318.0 | 34 |
Chemotherapy | |||
No | 1,613 | 20,383.6 | 216 |
Yes | 127 | 1,282.3 | 53 |
Radiotherapy | |||
No | 973 | 11,580.4 | 196 |
Yes | 767 | 10,085.5 | 73 |
a Weight (kg)/height (m)2.